These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12036181)

  • 1. Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition.
    Rouleau JR; Simard D; Rodrigue N; Blouin A; Kingma JG
    Auton Neurosci; 2002 Apr; 97(1):12-8. PubMed ID: 12036181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
    Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
    Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
    Kitakaze M; Asanuma H; Funaya H; Node K; Takashima S; Sanada S; Asakura M; Ogita H; Kim J; Hori M
    J Am Coll Cardiol; 2002 Jul; 40(1):162-6. PubMed ID: 12103271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chested dogs.
    Tayama S; Okumura K; Matsunaga T; Tsunoda R; Tabuchi T; Iwasa A; Yasue H
    Jpn Circ J; 1998 May; 62(5):371-8. PubMed ID: 9626906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
    Zanzinger J; Zheng X; Bassenge E
    Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy.
    Rouleau JR; Simard D; Blouin A; Kingma JG
    Basic Res Cardiol; 2002 Sep; 97(5):384-91. PubMed ID: 12200638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin inhibition on the coronary artery lower pressure limit in anesthetized dogs.
    Rouleau JR; Simard D; Kingma JG
    Can J Physiol Pharmacol; 2000 Nov; 78(11):892-6. PubMed ID: 11100937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
    Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
    Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
    Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
    Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH
    Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
    Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D
    Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile anaesthetics restore bradykinin and serotonin-induced coronary vasodilation after blocking nitric oxide synthase: lack of anaesthetic effects on KATP channels and prostaglandin pathways.
    Stowe DF; Heisner JS; Chung WW; Fujita S
    Eur J Anaesthesiol; 2001 Apr; 18(4):219-30. PubMed ID: 11350459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
    Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
    Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors.
    Danser AH; de Vries R; Schoemaker RG; Saxena PR
    J Hypertens; 1998 Feb; 16(2):239-44. PubMed ID: 9535152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase-independent effects of an ACE inhibitor on coronary flow response to bradykinin in aged mice.
    Talukder MA; Fujiki T; Morikawa K; Motoishi M; Matsuo Y; Hatanaka M; Tsutsui M; Takeshita A; Shimokawa H
    J Cardiovasc Pharmacol; 2004 Nov; 44(5):557-63. PubMed ID: 15505492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.
    Node K; Kitakaze M; Kosaka H; Minamino T; Mori H; Hori M
    Hypertension; 1998 Jun; 31(6):1290-8. PubMed ID: 9622144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.